Covimro

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCovimro
Drug Alias Nameagnostic orthomolecular compound (Covimro)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCoronavirus spike glycoprotein inhibitors
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)HIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCOVIMRO Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCOVIMRO Ltd
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)HIV Infections

Other Information

ATC CodeN/A
Related LinksN/A